DLA Piper represented NuVasive, Inc. in a US$98 million cash acquisition of Biotronic from Biotronic NeuroNetwork, a provider of intraoperative neurophysiological monitoring services. With the addition, NuVasive will double its neurophysiology footprint.

The acquisition allows NuVasive to expand its services related to spine procedures. The company will be able to better serve its health system customers by supporting clinical fulfillment through enhanced surgical monitoring and oversight capabilities, and increasing the breadth of products and services.

The DLA Piper team advising NuVasive was led by Larry Nishnick (San Diego).